TY - JOUR
T1 - Treatment of advanced gastric cancer with 5-fluorouracil and cisplatin in combination with dipyridamole
AU - Kohnoe, Shunji
AU - Maehara, Yoshihiko
AU - Takahashi, Ikuo
AU - Emi, Yasunori
AU - Baba, Hideo
AU - Sugimachi, Keizo
PY - 1998/12
Y1 - 1998/12
N2 - We investigated the efficacy of combination chemotherapy using 5- fluorouracil (5-FU), cisplatin (CDDP), and dipyridamole (DP), which is based on the concept of double biochemical modulation. Twenty-eight patients with advanced gastric cancer were treated with the simultaneous continuous intravenous (i.v.) infusion of 5-FU (800 mg/m2/day) and DP (4 mg/kg/day), and i.v. infusion of CDDP (20 mg/m2/day) for 5 days. The cycles were repeated every 4 weeks. Twelve patients (43%) had a partial response (PR), while stable disease (NC) occurred in 13 patients (46%), and progression (PD) in 3 patients (11%). An improved performance status was observed in 20 patients (71%). The carcinoembryonic antigen (CEA) level was markedly decreased in 75% of the CEA-positive patients. Toxicity was acceptable. The mean steady state plasma concentration of total DP was 6.4±0.5 μM, which thus seemed adequate to potentiate the cytotoxicity of 5-FU. The treatment regimen described herein thus appears to be effective, safe and well tolerated by patients with advanced gastric cancer.
AB - We investigated the efficacy of combination chemotherapy using 5- fluorouracil (5-FU), cisplatin (CDDP), and dipyridamole (DP), which is based on the concept of double biochemical modulation. Twenty-eight patients with advanced gastric cancer were treated with the simultaneous continuous intravenous (i.v.) infusion of 5-FU (800 mg/m2/day) and DP (4 mg/kg/day), and i.v. infusion of CDDP (20 mg/m2/day) for 5 days. The cycles were repeated every 4 weeks. Twelve patients (43%) had a partial response (PR), while stable disease (NC) occurred in 13 patients (46%), and progression (PD) in 3 patients (11%). An improved performance status was observed in 20 patients (71%). The carcinoembryonic antigen (CEA) level was markedly decreased in 75% of the CEA-positive patients. Toxicity was acceptable. The mean steady state plasma concentration of total DP was 6.4±0.5 μM, which thus seemed adequate to potentiate the cytotoxicity of 5-FU. The treatment regimen described herein thus appears to be effective, safe and well tolerated by patients with advanced gastric cancer.
UR - http://www.scopus.com/inward/record.url?scp=0031741961&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031741961&partnerID=8YFLogxK
U2 - 10.3892/ijo.13.6.1203
DO - 10.3892/ijo.13.6.1203
M3 - Article
C2 - 9824632
AN - SCOPUS:0031741961
VL - 13
SP - 1203
EP - 1206
JO - International Journal of Oncology
JF - International Journal of Oncology
SN - 1019-6439
IS - 6
ER -
